Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concurrent chemoradiation for cervical cancer: what should we do next?

× No keyword cloud information.

10 in total

1. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.

Authors: Takafumi Toita; Katsumasa Nakamura; Takashi Uno; Takeshi Kodaira; Atsunori Shinoda; Kazuhiko Ogawa; Norio Mitsuhashi; Katsuya Maebayashi; Atsuko Kawaguchi; Toshihiko Inoue; Teruki Teshima
Journal: Jpn J Clin Oncol Date: 2005-03 Impact factor: 3.019

2. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.

Authors: R Pearcey; M Brundage; P Drouin; J Jeffrey; D Johnston; H Lukka; G MacLean; L Souhami; G Stuart; D Tu
Journal: J Clin Oncol Date: 2002-02-15 Impact factor: 44.544

3. Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: a phase I study in Japanese patients with cancer of the uterine cervix.

Authors: Yoh Watanabe; Hidekatsu Nakai; Masao Shimaoka; Takako Tobiume; Isao Tsuji; Hiroshi Hoshiai
Journal: Int J Clin Oncol Date: 2006-08 Impact factor: 3.402

4. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Authors: M Morris; P J Eifel; J Lu; P W Grigsby; C Levenback; R E Stevens; M Rotman; D M Gershenson; D G Mutch
Journal: N Engl J Med Date: 1999-04-15 Impact factor: 91.245

5. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Authors: P G Rose; B N Bundy; E B Watkins; J T Thigpen; G Deppe; M A Maiman; D L Clarke-Pearson; S Insalaco
Journal: N Engl J Med Date: 1999-04-15 Impact factor: 91.245

6. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Authors: C W Whitney; W Sause; B N Bundy; J H Malfetano; E V Hannigan; W C Fowler; D L Clarke-Pearson; S Y Liao
Journal: J Clin Oncol Date: 1999-05 Impact factor: 44.544

7. Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin.

Authors: Hitoshi Ikushima; Kyousuke Osaki; Shunsuke Furutani; Kyou Yamashita; Takashi Kawanaka; Yoshiomi Kishida; Seiji Iwamoto; Yoshihiro Takegawa; Takaharu Kudoh; Hiromu Nishitani
Journal: Radiat Med Date: 2006-02

8. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

Authors: H M Keys; B N Bundy; F B Stehman; L I Muderspach; W E Chafe; C L Suggs; J L Walker; D Gersell
Journal: N Engl J Med Date: 1999-04-15 Impact factor: 91.245

9. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.

Authors: Takafumi Toita; Yasumasa Kakinohana; Kazuhiko Ogawa; Genki Adachi; Hidehiko Moromizato; Yutaka Nagai; Toshiyuki Maehama; Kaoru Sakumoto; Koji Kanazawa; Sadayuki Murayama
Journal: Int J Radiat Oncol Biol Phys Date: 2003-08-01 Impact factor: 7.038

10. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.

Authors: Krystyna Serkies; Jacek Jassem
Journal: Int J Radiat Oncol Biol Phys Date: 2004-11-01 Impact factor: 7.038

10 in total